scholarly article | Q13442814 |
P50 | author | Shixiu Wu | Q88423064 |
P2093 | author name string | Peng Chen | |
Tao Song | |||
Xuebang Zhang | |||
Min Fang | |||
Dexi Du | |||
P2860 | cites work | Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. | Q53395748 |
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | Q57259796 | ||
Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term | Q87449409 | ||
Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey | Q92566352 | ||
Cancer statistics, 2014 | Q27861018 | ||
Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis | Q28087347 | ||
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma | Q32033905 | ||
Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma | Q33388978 | ||
Combination of taxanes with radiation: preclinical studies | Q33598037 | ||
A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients | Q35611924 | ||
Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy | Q36213998 | ||
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | Q37449181 | ||
Impact of postoperative radiation after esophagectomy for esophageal cancer | Q37653973 | ||
Radiation therapy in the postoperative management of esophageal cancer | Q38027516 | ||
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial | Q38374359 | ||
International survey on esophageal cancer: part II staging and neoadjuvant therapy | Q40005311 | ||
Cancer statistics in China, 2015. | Q40064386 | ||
Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma | Q44200115 | ||
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. | Q46675470 | ||
Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis | Q47283231 | ||
Role of Postoperative Concurrent Chemoradiotherapy for Esophageal Carcinoma: A meta-analysis of 2165 Patients. | Q50300226 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
P304 | page(s) | 1631-1639 | |
P577 | publication date | 2020-03-05 | |
P1433 | published in | Cancer Management and Research | Q5031417 |
P1476 | title | The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma | |
P478 | volume | 12 |
Search more.